IMMX
Price
$4.80
Change
-$0.19 (-3.81%)
Updated
Dec 8, 6:59 PM EST
82 days until earnings call
VSTM
Price
$7.36
Change
-$0.23 (-3.03%)
Updated
Dec 8, 6:59 PM EST
Ad is loading...

Compare trend and price IMMX vs VSTM

Header iconIMMX vs VSTM Comparison
Open Charts IMMX vs VSTMBanner chart's image
Immix Biopharma
Price$4.80
Change-$0.19 (-3.81%)
Volume$74.74K
CapitalizationN/A
Verastem
Price$7.36
Change-$0.23 (-3.03%)
Volume$29.98K
CapitalizationN/A
View a ticker or compare two or three
IMMX vs VSTM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
IMMX vs. VSTM commentary
Dec 09, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a StrongSell and VSTM is a StrongBuy.

COMPARISON
Comparison
Dec 09, 2023
Stock price -- (IMMX: $4.97 vs. VSTM: $7.57)
Brand notoriety: IMMX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 43% vs. VSTM: 107%
Market capitalization -- IMMX: $99.53M vs. VSTM: $165.5M
IMMX [@Biotechnology] is valued at $99.53M. VSTM’s [@Biotechnology] market capitalization is $165.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMMX and VSTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 3 TA indicator(s) are bullish while VSTM’s TA Score has 5 bullish TA indicator(s).

  • IMMX’s TA Score: 3 bullish, 5 bearish.
  • VSTM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than IMMX.

Price Growth

IMMX (@Biotechnology) experienced а -2.74% price change this week, while VSTM (@Biotechnology) price change was +9.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10152.33%. For the same industry, the average monthly price growth was +10.42%, and the average quarterly price growth was +27.78%.

Reported Earning Dates

IMMX is expected to report earnings on Feb 28, 2024.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+10152.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMMX with price predictions.
OPEN
A.I.dvisor published
a Summary for VSTM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VSTM($166M) has a higher market cap than IMMX($99.5M). IMMX YTD gains are higher at: 109.607 vs. VSTM (56.729). IMMX has higher annual earnings (EBITDA): -14.21M vs. VSTM (-73.06M). VSTM has more cash in the bank: 166M vs. IMMX (19.6M). IMMX has less debt than VSTM: IMMX (50K) vs VSTM (42M). IMMX (0) and VSTM (0) have equivalent revenues.
IMMXVSTMIMMX / VSTM
Capitalization99.5M166M60%
EBITDA-14.21M-73.06M19%
Gain YTD109.60756.729193%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.6M166M12%
Total Debt50K42M0%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBLYX19.01N/A
N/A
Fidelity Advisor® Global Equity Inc A
FNCSX30.29N/A
N/A
Franklin Natural Resources R6
ZIFIX9.31N/A
N/A
Ninety One International Franchise I
HIOCX14.06N/A
N/A
Hartford International Opportunities C
NRIFX20.20N/A
N/A
Nuveen Real Asset Income R6

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and AVRO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and AVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-3.42%
AVRO - IMMX
30%
Poorly correlated
+2.17%
ORMP - IMMX
27%
Poorly correlated
-0.88%
PDSB - IMMX
25%
Poorly correlated
+0.59%
PRTC - IMMX
24%
Poorly correlated
+7.44%
REVB - IMMX
24%
Poorly correlated
+3.45%
More